Marketing authorization granted for darolutamide in Japan

NEXT STORY
Curetis To Attend Key Conferences in the First Half of 2020
PREV STORY
Basilea berichtet auf ASCO Gastrointestinal Cancers Symposium über Aktivität von Derazantinib in präklinischen Magenkrebs-Modellen
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aduro Biotech and UC Berkeley Launch Industry-Leading Immunotherapeutics and Vaccine Research Initiative

Collaboration to Accelerate Breakthroughs in the Treatment and Prevention of Cancer, Infectious and Autoimmune ...

author_avatar
NASDAQ Market News

ContraFect Announces Additional $2.3 Million in Funding from CARB-X to Support Gram-Negative Lysin Program

YONKERS, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology ...

author_avatar
NASDAQ Market News

Immunicum AB: The Nomination Committee of Immunicum AB (publ) proposes Michael Oredsson as new Chairman of the Board

Press Release 14 March 2018 The Nomination Committee of Immunicum AB (publ) proposes Michael ...

author_avatar
NASDAQ Market News